Algernon Pharmaceuticals

Developer of small molecules for chronic kidney disease and inflammatory bowel diseases

placeVancouver, British Columbia, Canada calendar_todayFounded 2015 groups1 employees language algernonpharmaceuticals.com

Registered entities

Innovation

11 patent families (3 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 216 times.

YearFilings
20207
20216
20226
20233
20242
20253

Investor mix

1 investor on record.

Investor typeCountShare
Venture capital1100%
Coming soon